METHOD DEVELOPMENT AND VALIDATION OF UV-VISIBLE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF ASSAY OF SUGAMMADEX SODIUM, APREMILAST, RIOCIGUAT AND VORAPAXAR SULFATE DRUGS IN API FORM.
Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2017, Vol 10, Issue 2
Abstract
Objective: The objective of the present work is to develop a simple, efficient and reproducible spectrophotometric method for the quantitative estimation of Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate drugs in its active pharmaceutical ingredient (API) form.Methods: The developed UV-Visible spectrophotometric method for the quantitative estimation of drugs – Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate is based on measurement of absorption at a wavelength maximum (λmax) of 210nm, 230nm, 323nm and 271nm using water and methanol as diluents.Results: The method was validated in terms of specificity, precision, linearity, accuracy, and robustness as per the ICH guidelines. The method was found to be linear in the range of 33% to 167% for Sugammadex Sodium and Apremilast drug substances; 50% to 150% for Riociguat and Vorapaxar sulfate drug substances. The percentage recovery values were in the range of 99.7 to 100.9% for Sugammadex Sodium, 99.3 to 100.3% for Apremilast, 99.7 to 100.3% for Riociguat and in the range of 99.5 to 100.3% for Vorapaxar sulfate at different concentration levels. Relative standard deviation for precision and intermediate precision results were found to be less than 2%. The correlation co-efficient value observed for Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate drug substances was not less than 0.99 for their respective drugs. Results obtained from the validation experiments prove that the developed method is quantified for the estimation of assay of Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate drug substances.Conclusion: The developed method can be successfully applied for routine analysis, quality control analysis and also suitable for stability analysis of assay of Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate in API form as per the regulatory requirements.Keywords: Sugammadex Sodium, Apremilast, Riociguat, Vorapaxar sulfate, Method Development, Validation, UV-Visible spectrophotometry.
Authors and Affiliations
V Ashok Chakravarthy, V Sailaja Bb, Praveen Kumar A
Keywords
Related Articles
- EP ID EP605443
- DOI 10.22159/ajpcr.2017.v10i2.15502
- Views 74
- Downloads 0
COMMIPHORA MUKUL EXTRACT AND GUGGULSTERONE EXHIBIT ANTITUMOUR ACTIVITY THROUGH INHIBITION OF CYCLIN D1, NF-Κß AND INDUCTION OF APOPTOSIS IN ORAL CANCER CELLS
ABSTRACTComiphora mukul, a promising medicinal plant and its constituent Guggulsterone (GS) is used in Ayurveda since decades. This study was aimed toinvestigate the anticancer potential of C. mukul and GS on oral cancer...
DESIGN, DEVELOPMENT, AND EVALUATION OF AN ION-ACTIVATED OPHTHALMIC IN SITU GEL OF MOXIFLOXACIN HYDROCHLORIDE
Objective: The objective of this study was to develop an in situ ophthalmic gel of an anti-infective drug, moxifloxacin (MOX) hydrochloride (HCL), for sustained ocular delivery for the treatment of bacterial infections o...
GENOPROTECTIVE EFFECTS OF ETHANOLIC STEM EXTRACTS OF TINOSPORA CORDIFOLIA ON SODIUM ARSENITE-INDUCED DNA DAMAGE IN SWISS MICE LYMPHOCYTES BY COMET ASSAY
Objective: The study was aimed to evaluate the DNA protective effects of ethanolic extracts of Tinospora cordifolia stem on Swiss albino mice lymphocytes against the sodium arsenite-induced genotoxicity. Methods: In thi...
ALOE VERA: AN ASSURED WEIGHT LOSS DIET – AN APPROACH TOWARD IMPROVING THE JUICE PALATABILITY AND IN SILICO ANALYSIS
Objective: Obesity is an epidemic disease act as causative for global death. The principal aim of this study is to create an obesity treatment beverage that is palatable and readily acceptable to the public. Aloe vera ju...
5TH INTERNATIONAL POSTGRADUATE CONFERENCE ON PHARMACEUTICAL SCIENCES 2017 (IPOPS 2017)
FACULTY OF PHARMACY UITM SELANGOR